Neurology News

If you’re an owner of a practice that has decided to pursue a sale transaction, you have likely been working for months with your partners and advisers to explore the market, evaluate potential buyers and negotiate key deal terms.

The U.S. Department of Defense has awarded $11.4 million to a Boston-based biotherapeutics firm to advance its novel oral prodrug of endogenous allopregananolone, LYT-300, to treat Fragile X-associated Tremor Ataxia syndrome.

Early menopause and vascular processes may synergistically contribute to increased risk for Alzheimer’s disease in women, according to a poster presentation at the Alzheimer’s Association International Conference.

Large differences in some modifiable risk factors for stroke between Black and non-Black patients were resolved after a 1-year intensive intervention that included medical management, follow-up and lifestyle coaching, researchers reported.

Treatment with atogepant at 30 mg and 60 mg reduced mean monthly migraine days over 12 weeks compared with placebo, while showing good safety and tolerability profiles, according to research published in the Lancet Neurology.

AUSTIN, Texas — More than 80% of those dealing with migraine or severe headaches reported cognitive impairment, with the most common being concentration difficulty, according to a presenter at the American Headache Society annual meeting.

Quest Diagnostics has announced the availability of a blood-based test that assesses the risk of developing Alzheimer’s disease through amyloid-beta biomarkers.

NYU Langone Hospitals was named the top hospital in the United States for neurology and neurosurgery by the U.S. News & World Report’s annual Best Hospitals survey.

A clinical-stage biopharmaceutical company and a global contract research organization have partnered to support the ongoing development of investigational, psychedelic therapeutics to treat a range of psychiatric disorders.

Most investors, when considering their financial future, have a common number one concern – that they will not have saved enough to sustain them in retirement. In other words, they fear that they will outlive their money.